These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 18699761)

  • 1. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin: a review of approved uses.
    Stein A; Arnold D
    Expert Opin Pharmacother; 2012 Jan; 13(1):125-37. PubMed ID: 22149372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin in the treatment of colorectal cancer.
    Kim GP; Erlichman C
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):281-94. PubMed ID: 17428157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of oxaliplatin: an active platinum agent in colorectal cancer.
    Cassidy J
    Int J Clin Pract; 2000; 54(6):399-402. PubMed ID: 11092115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic options in colon cancer: focus on oxaliplatin.
    Wilkes GM
    Clin J Oncol Nurs; 2002; 6(3):131-7. PubMed ID: 11998605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

  • 8. Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.
    Grothey A
    Oncology; 2010; 79(5-6):389-99. PubMed ID: 21447970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives in the treatment of colorectal cancer.
    Ozer H; Diasio RB
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):14-8. PubMed ID: 15726534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy for metastatic colorectal cancer].
    Iwasa S; Shimada Y
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.
    Zeh HJ; Brown CK; Holtzman MP; Egorin MJ; Holleran JL; Potter DM; Bartlett DL
    Ann Surg Oncol; 2009 Feb; 16(2):385-94. PubMed ID: 19034580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.
    Kweekel DM; Gelderblom H; Guchelaar HJ
    Cancer Treat Rev; 2005 Apr; 31(2):90-105. PubMed ID: 15847979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin: practical guidelines for administration.
    Sorich J; Taubes B; Wagner A; Hochster H
    Clin J Oncol Nurs; 2004 Jun; 8(3):251-6. PubMed ID: 15208819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
    Sabharwal A; Kerr D
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):477-87. PubMed ID: 17428169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
    Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
    Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.
    Tonini G; Santini D; Vincenzi B; Borzomati D; Dicuonzo G; La Cesa A; Onori N; Coppola R
    J Biol Regul Homeost Agents; 2002; 16(2):105-9. PubMed ID: 12144121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC).
    Berretta M; Zanet E; Nasti G; Lleshi A; Frustaci S; Fiorica F; Bearz A; Talamini R; Lestuzzi C; Lazzarini R; Fisichella R; Cannizzaro R; Iaffaioli RV; Berretta S; Tirelli U
    Arch Gerontol Geriatr; 2012; 55(2):271-5. PubMed ID: 21937127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.